Life ScienceCompany
GenePOC - State-of-the-Art Molecular Diagnostics Platform Ownership
Who owns GenePOC - State-of-the-Art Molecular Diagnostics Platform?
GenePOC - State-of-the-Art Molecular Diagnostics Platform is owned by Meridian Bioscience. It was acquired on April 30, 2019.
GenePOC - State-of-the-Art Molecular Diagnostics Platform Business Overview
Where is GenePOC - State-of-the-Art Molecular Diagnostics Platform headquartered?
GenePOC - State-of-the-Art Molecular Diagnostics Platform is headquartered in Québec, Quebec.
What sector is GenePOC - State-of-the-Art Molecular Diagnostics Platform in?
GenePOC - State-of-the-Art Molecular Diagnostics Platform is a life science company.
Life Science M&A Summary in 2019
Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2019. The largest life science acquisition in 2019 was Celgene - which was acquired by Bristol-Myers Squibb for $74.0B.
Join Mergr to view all 251 acquisitions of life science companies in 2019, including 44 acquisitions by private equity firms, and 207 by strategics.